SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影響因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (ENDOC

只看該作者 · 發(fā)表于 2025-3-21 19:47:03

SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)影響因子

SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)影響因子@(內(nèi)分泌學(xué)和代謝學(xué))學(xué)科排名

SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)總引論文

SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)總引論文@(內(nèi)分泌學(xué)和代謝學(xué))學(xué)科排名

SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)影響因子

SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)總引頻次@(內(nèi)分泌學(xué)和代謝學(xué))學(xué)科排名

SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)即時影響因子

SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)即時影響因子@(內(nèi)分泌學(xué)和代謝學(xué))學(xué)科排名

SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)五年累積影響因子

SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)五年累積影響因子@(內(nèi)分泌學(xué)和代謝學(xué))學(xué)科排名

只看該作者 · 發(fā)表于 2025-3-21 23:35:17

Submitted on: 15 November 2020. Revised on: 09 March 2021. Accepted on: 07 May 2021. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

只看該作者 · 發(fā)表于 2025-3-22 03:23:15

只看該作者 · 發(fā)表于 2025-3-22 07:24:26

只看該作者 · 發(fā)表于 2025-3-22 08:58:37

只看該作者 · 發(fā)表于 2025-3-22 15:20:50

Submitted on: 29 May 1999. Revised on: 16 August 1999. Accepted on: 26 September 1999. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

只看該作者 · 發(fā)表于 2025-3-22 18:54:27

Submitted on: 05 October 2001. Revised on: 21 November 2001. Accepted on: 03 December 2001. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

只看該作者 · 發(fā)表于 2025-3-23 00:24:49

Submitted on: 26 April 2024. Revised on: 29 June 2024. Accepted on: 24 August 2024. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

只看該作者 · 發(fā)表于 2025-3-23 05:08:10

Submitted on: 21 September 2003. Revised on: 31 December 2003. Accepted on: 10 February 2004. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

只看該作者 · 發(fā)表于 2025-3-23 07:11:14

Submitted on: 11 May 1999. Revised on: 03 June 1999. Accepted on: 02 August 1999. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-27 07:55
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved